iShares Biotechnology ETF
399 hedge funds and large institutions have $6.62B invested in iShares Biotechnology ETF in 2015 Q1 according to their latest regulatory filings, with 70 funds opening new positions, 144 increasing their positions, 113 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 369 → 399 (+30)
56% less call options, than puts
Call options by funds: $479M | Put options by funds: $1.09B
Holders
399
Holding in Top 10
33
Calls
$479M
Puts
$1.09B
Top Buyers
| 1 | +$584M | |
| 2 | +$290M | |
| 3 | +$206M | |
| 4 |
Citigroup
New York
|
+$130M |
| 5 |
Morgan Stanley
New York
|
+$86.5M |
Top Sellers
| 1 | -$467M | |
| 2 | -$142M | |
| 3 | -$128M | |
| 4 |
Barclays
London,
United Kingdom
|
-$104M |
| 5 |
Jane Street
New York
|
-$41.1M |